EAHP represents over 29,000 hospital pharmacists across 36 member countries. EAHP represents and develops the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.
The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The EAHP staff supports the Board in executing EAHP’s mission. The Staff assists in financial management, events organisations, policy activities and all EAHP projects. The EAHP staff works closely with EAHP’s members and ensures the effective communication all relevant stakeholders.
The first member countries were Belgium, Britain, Denmark, France, the Federal Republic of Germany and The Netherlands in 1972. EAHP has now 36 EAHP members and 2 Associate Members. EAHP is open to countries members of the Council of Europe and since 2022 to organisations representing the interests of hospital pharmacists from outside the Council of Europe (Associate Membership)
EAHP’s structure is also composed by different standing committes: EAHP Scientific Committee, EAHP Education Executive Committee and the EAHP CTF Steering Committee.
At EAHP, we are committed to transparency in our governance, ethical standards, and funding practices. This section provides open access to our foundational documents, including the EAHP Statutes, Code of Conduct, and Funding Sources. By sharing these resources, we aim to uphold accountability and foster trust with our members, partners, and the public.
Keep up with all EAHP’s events and webinars. Contact the team at info@eahp.eu should you have any questions about upcoming events or activities.
Here you can find all upcoming events organised by EAHP and by all its members and associate members. Do not hesitate to contact the events team at events@eahp.eu should you have any questions about the organisation of these events.
Hospital pharmacists conduct a critical role in the care of patients in hospitals. Learn more about what they do here and in all the pages under Hospital Pharmacy practice and Policy.
Self-Assessment
SILCC
Closed SIGs
EAHP brings together experts from many areas of hospital pharmacy practice providing and highlighting good local sustainable practices as that can be up-scaled and shared with other countries. The EAHP Working Group on Sustainability has the aim of reducing the environmental burden of the hospital pharmacy services.
The European Association of Hospital Pharmacists (EAHP), and its 36 member country platforms are creating a Common Training Framework for the hospital pharmacy education in Europe. The goal of this project is to allow the free movement of hospital pharmacists within the European Union.
The European Association of Hospital Pharmacists (EAHP) and the European Society of Clinical Pharmacy (ESCP) have collaboratively developed the Oath to Society. The Oath to Society is all encompassing and acts as a contract for excellence in providing compassionate patient care, working as part of the healthcare team and advancing the pharmacy profession, and showcasing how clinical and hospital pharmacists work every day
A day created to highlight the importance and to celebrate the work done by hospital pharmacies. This day celebrates all hospital pharmacy teams.
Catch up with EAHP’s press releases
Find all EAHP relevant publication like the EAHP Surveys, annual reports and the history books.
The European Journal of Hospital Pharmacy (EJHP) is the only official journal of the European Association of Hospital Pharmacists (EAHP) and is committed to advancing the science, practice and profession of hospital pharmacy. As the premier communication platform for hospital pharmacists worldwide, EJHP is a major source for continuing education as well as updates on advances in the practice and standard of pharmaceutical care for patients.
When EAHP and Hospital pharmacists appear in the news.
EAHP publishes a monthly EU monitor with updates about the latest EAHP initiatives and information relevant for the hospital pharmacy profession.
Sponsor Channel
The Sponsor Channel is designed to maximise visibility and engagement, allowing sponsors to connect with the hospital pharmacy community and partners in a dynamic and interactive environment. From product demonstrations to networking sessions, the Sponsor Channel offers a range of opportunities for sponsors to showcase their offerings and generate leads in the new EAHP Website.
The EAHP EU Monitor is a regular round up of news relevant to hospital pharmacy in Europe.
You can subscribe to receive the EAHP EU Monitor by email HERE.
The deadline for the submission of abstracts to the 25th Congress of the European Association of Hospital Pharmacists (EAHP) is fast approaching. By 15th October 2019 hospital pharmacists, other healthcare professionals and interested scientists can submit their work for the consideration by EAHP’s Scientific Committee.
The 25th Congress of EAHP will be held in Gothenburg, Sweden from 25th to 27th March 2020. Different seminars, workshops and keynotes will be organised around the theme: “Hospital Pharmacy 5.0 – the future of patient care”. Abstract authors are kindly reminded to carefully read and comply with the guidelines presented on EAHP’s website which outline the review process, provide guidance to those submitting abstracts for the first time and list tips on avoiding abstract rejection. Submissions of abstracts from all disciplines of hospital pharmacy or related areas are encouraged, provided that they can be linked to one of the 44 European Statements of Hospital Pharmacy.
Abstracts must be written in accordance with a pre-defined structure (background, purpose, materials and methods, results, conclusions) and they should not exceed the limit of 350 words. The online submission system will guide abstract authors through the process. Questions concerning the abstract submission process can be addressed to abstract@eahp.eu
The best abstracts/posters, with regards to aspects like originality, scientific quality and practical applicability, will be awarded with 3 prizes amounting to 750 euro, 500 euro and 250 euro.
More information HERE
Between 2nd and 4th October, the European Health Forum Gastein (EHFG) discussed topics relevant to the European public health community around the theme: “A healthy dose of disruption”. EAHP President Petr Horák attended this conference and shared the views of hospital pharmacists during the session “Shortages of essential medicines” which discussed if patients can expect the adoption of effective measures ensure the availability of their medicines.
Together with Brigitte Zarfl (Minister of Labour, Social Affairs, Health and Consumer Protection of Austria), Kristin Raudsepp (Director General, State Agency of Medicines of Estonia & Co-Chair of the EMA-HMA Task Force on Availability of Authorized Medicines) and Richard Bergström (VP Life Sciences at Guardtime), Petr Horák discussed the problems caused by medicines shortages and proposed possible solutions that could help alleviate the problem. The scene for the discussion was set by Vytenis Andriukaitis, the European Commissioner for Health and Food Safety, who stressed the importance of transparency and the need for early notification to healthcare professionals and patients.
After listening to the country perspectives which highlighted measures taken and called for a stronger cooperation of regulators, EAHP’s President shed some light on the daily problems faced by hospital pharmacists. He underlined the need for data, in particular on the causes of medicines and stressed that only detailed information can help to identify the best suitable solutions for each Member State. Given the worsening of the situation, which was also reported on in EAHP’s 2018 Medicines Shortages Survey, Petr Horák called for the adoption of more proactive and less reactive measures. These include for example prudent tendering procedures which seek to minimise medicines shortages.
More information about the EHFG is available HERE
At the end of September, EAHP attended the 79th World Congress of Pharmacy and Pharmaceutical Sciences organised by the International Pharmaceutical Federation (FIP). The event brought together member representatives from all over the globe to discuss the new horizons for the pharmacy.
One of the main items on the agenda was the presentation of FIP’s global strategy for pharmacy which aims at providing access to medicines for everyone. In addition, pharmacists strengthened their commitment in the fight against non-communicable diseases (NCDs) through the adoption of a new Statement which touches upon the contribution of the pharmacy profession to the prevention of NCDs, and the optimal detection and care of patients living with NCDs. Another statement of policy which was shared during the FIP Congress focuses on empowering informal carers. It urges pharmacists to further the support they give to women to provide caregiving at home.
Rob Moss, EAHP’s Director of Professional Development, receive a FIP Fellowship. This award recognises individual members of FIP who have exhibited strong leadership internationally, distinguished themselves in the practice of pharmacy and contributed to its advancement.
Learn more about FIP HERE
EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) has recommended limiting the use of high-strength creams containing 100 micrograms/gram (0.01%) of estradiol to a single treatment period of up to 4 weeks. This measure is intended to minimise the risk of side effects caused by estradiol absorbed into the bloodstream from creams applied inside the vagina to treat symptoms of vaginal atrophy in women who have been through menopause.
The PRAC has reviewed available data on the safety and effectiveness of high-strength estradiol-containing creams, including data on the amount of estradiol in the blood. These data showed that in postmenopausal women who had used these creams, the levels of estradiol in the blood were higher than normal postmenopausal levels. The PRAC concluded that absorption of estradiol into the bloodstream is of concern and could result in similar side effects to those seen with hormone replacement therapy (HRT). The side effects of HRT taken orally or used transdermally (as patches) include venous thromboembolism (formation of blood clots in the veins), stroke, endometrial cancer (cancer of the lining of the womb) and breast cancer.
The prescribing information for these creams will be updated with the new recommendations. A warning that the medicine is to be used for a single treatment period of up to 4 weeks only will be placed on the outer and inner packaging and the size of the tube will be limited to 25 grams to prevent use for longer than recommended.
The PRAC recommendations will now be sent to the CMDh to make a decision about their implementation.
For more information, please click here.
The online first edition of the European Journal of Hospital Pharmacy (EJHP) published a retrospective analysis on the epidemiological aspects and prevalence study of nosocomial infections in a general hospital of specialties covering the years 2012 to 2017. It was concluded that the multidisciplinary nature of the nosocomial infections allows to improve their approach, reducing the harmful effects on health.
Read the article HERE
To promote the implementation of the European Statements of Hospital Pharmacy at national level EAHP has teamed up with motivated and enthusiastic hospital pharmacists willing to help their countries and others move towards Statement Implementation, the so call “Implementation Ambassadors”. It is their role to
In case you are curious about the Implementation Ambassador working in your country you can find out more about him/her via the Statement website.
